Trial Profile
Elucidation of Mechanisms Underlying Prolonged Glucose-lowering Effect of Exenatide LAR in Japanese T2DM Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 May 2016
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 27 May 2016 New trial record